EN

Campuses

As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.

Discover >

Campus life

Discover the campuses

Advantages

Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.

Discover >

Join our programs

Shaker Gene.iO ATIGE

Genopole’s citizens

Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.

Discover >

Directories Our network

Highlights

Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.

Discover >

Come to our events

Innovate with us

Discover >

Quick access

Company

Floating Genes

Pépinière Genopole Entreprises
4, rue Pierre Fontaine – Genopole Campus 3
91058 EVRY Cedex – France

Gabriel LEREBOURS-PIGEONNIERE: CEO
Dipanwita BISWAS: CSO
Floating Genes - entreprises génopolitaines Floating Genes - entreprises génopolitaines

Shaker#Diagnostics #Medical devices

  • Oncology
  • BoosterIn vitro diagnosis
  • Liquid biopsy
  • Genetics

 

Field of Activity

Floating Genes develops diagnostic tools for use in liquid biopsies via the highly sensitive NGS detection of circulating tumor DNA.

Background
In 2020, Dr. Dipanwita Biswas conceptualized a method to detect rare mutations in liquid biopsies, validated it in Genopole’s Shaker program and, in October 2021, founded Floating Genes.

Description of the Products / Services / Technology
The start-up is developing tools for the early detection of cancer in liquid biopsies. The initial approach comprises two principal components: a kit with “Enhance-seq” technology reagents, and a computer program to analyze next-generation sequencing data.

Customer references / Partnerships / Highlights
The project was chosen for Genopole’s Shaker program where its proof of concept was achieved. The project demonstrated its feasibility in a synthetic system. A Wilco and Réseau Entreprendre laureate, Floating Genes was selected then accredited by the Cancer Campus’s OncoEntrepreneur program at the OncoSTART and IFODS conference and by the EIT Health WildCard program.

Partnerships Sought
Floating Genes is looking for scientific and clinical partnerships with, e.g., hospitals and biobanks (liquid biopsy samples) and experts in genetics and microfluidics.

 

  • More information

    1 patent

    2 staff members

    STRENGTHS:
    Ultra-sensitive technology for the detection of rare mutations.

    INNOVATION ASSETS:
    A low sequencing depth is sufficient for the technology.

Share
Genopole’s Companies

#Diagnostics

In the same field

CGenetix - Entreprise génopolitaine

CGenetix

CGenetix, is a medTech start-up developing in vitro medical diagnostic devices for the follow-up of transplant patients.

Discover
EndoGene.Bio - Genopole's Company

EndoGene.Bio

Research & development for an in vitro diagnostic tool for endometriosis

Discover
SafeInsight - Entreprise génopolitaine

SafeInsight

SafeInsight seeks to provide a response to the growing concerns of consumers for the composition of the products they buy and accompanies manufacturers aiming to attentively circumscribe the problem of endocrine disruptors.

Discover
Cell Environment - Genopole's company

Cell Environment

Cell Environment is a company focusing on DNA damage detection involving unique and repeated sequences such as telomere and centromere sequences.

Discover
Innovhem - Entreprise génopolitaine

Innovhem

Our mission is to improve the management of Red Blood Cell diseases and in particular Sickle Cell Disease

Discover
IntegraGen - Genopole's Company

Integragen

IntegraGen’s mission is to translate molecular research to clinical practice through the identification of novel genetic biomarkers and the subsequent commercialization of molecular diagnostic tests based on these discoveries.

Discover
Enalees - Genopole Company 2024

Enalees

Enalees conceives, develops and markets next-generation rapid molecular diagnosis tests for veterinarians, and furthermore screening tests for SARS-CoV-2.

Discover
View all >
With the support from
Région île de France
Ministère de l'Enseignement supérieur et de la recherche AFM-Téléthon
Communauté d'agglomération Grand Paris Sud
Département de l'Essonne - Terre D'avenirs Ville d'Evry-Courcouronnes 2023 CEA Inserm Centre hospitalier Sud Francilien Université d'Evry - Paris Saclay Université PAris-Saclay SEM Genopole

Keep up to date with Genopole’s latest events and news